Green tea catechin, epigallocatechin-3-gallate, attenuates the cell viability of human non-small-cell lung cancer A549 cells via reducing Bcl-xL expression

Experimental and Therapeutic Medicine

Volumn 8, Issue 1, 2014, Pages 59-63

  Sonoda, Jun Ichiro ^a   Ikeda, Ryuji ^b   Baba, Yasutaka ^c   Narumi, Keiko ^a   Kawachi, Akio ^a   Tomishige, Erisa ^a   Nishihara, Kazuya ^a   Takeda, Yasuo ^b   Yamada, Katsushi ^d   Sato, Keizo ^a   Motoya, Toshiro ^a  

^a KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

^d NAGASAKI INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

A549 cells; Apoptosis; B cell lymphoma extra large; Epigallocatechin 3 gallate

Indexed keywords

CATECHIN; DNA POLYMERASE; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; MESSENGER RNA; PROTEIN BCL XL;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MTT ASSAY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

EID: 84901291322     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1719     Document Type: Article

References (32)

1. Baba Y, Sonoda JI, Hayashi S, et al: Reduction of oxidative stress in liver cancer patients by oral green tea polyphenol tablets during hepatic arterial infusion chemotherapy. Exp Ther Med 4: 452-458, 2012.
2. Lee IP, Kim YH, Kang MH, et al: Chemopreventive effect of green tea (Camellia sinensis) against cigarette smoke-induced mutations (SCE) in humans. J Cell Biochem Suppl 27: 68-75, 1997.
3. Shimizu M, Fukutomi Y, Ninomiya M, et al: Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol Biomarkers Prev 17: 3020-3025, 2008.
4. Khan N, Adhami VM and Mukhtar H: Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies. Nutr Cancer 61: 836-841, 2009.
5. Suganuma M, Saha A and Fujiki H: New cancer treatment strategy using combination of green tea catechins and anticancer drugs. Cancer Sci 102: 317-323, 2011.
6. Imai K, Suga K and Nakachi K: Cancer-preventive effects of drinking green tea among a Japanese population. Prev Med 26: 769-775, 1997.
7. Inoue M, Tajima K, Mizutani M, et al: Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett 167: 175-182, 2001.
8. Bettuzzi S, Brausi M, Rizzi F, et al: Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res 66: 1234-1240, 2006.
9. Naganuma T, Kuriyama S, Kakizaki M, et al: Green tea consumption and hematologic malignancies in Japan: the Ohsaki study. Am J Epidemiol 170: 730-738, 2009.
10. Nishikawa T, Nakajima T, Moriguchi M, et al: A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins. J Hepatol 44: 1074-1082, 2006.
11. Yamauchi R, Sasaki K and Yoshida K: Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549. Toxicol In Vitro 23: 834-839, 2009.
12. Li HC, Yashiki S, Sonoda J, et al: Green tea polyphenols induce apoptosis in vitro in peripheral blood T lymphocytes of adult T-cell leukemia patients. Jap J Cancer Res 91: 34-40, 2000.
13. Tsukahara T, Kannagi M, Ohashi T, et al: Induction of Bcl-x(L) expression by human T-cell leukemia virus type 1 Tax through NF-kappaB in apoptosis-resistant T-cell transfectants with Tax. J Virol 73: 7981-7987, 1999.
14. Ahmad N, Gupta S and Mukhtar H: Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor κB in cancer cells versus normal cells. Arch Biochem Biophys 376: 338-346, 2000.
15. Sonoda J, Koriyama C, Yamamoto S, et al: HTLV-1 provirus load in peripheral blood lymphocytes of HTLV-1 carriers is diminished by green tea drinking. Cancer Sci 95: 596-601, 2004.
16. Khoshnan A, Tindell C, Laux I, et al: The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes. J Immunol 165: 1743-1754, 2000.
17. Bui NT, Livolsi A, Peyron JF and Prehn JH: Activation of nuclear factor kappaB and Bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of IkappaBalpha. J Cell Bio 152: 753-764, 2001.
18. Carmichael J, DeGraff WG, Gazdar AF Minna JD and Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936-942, 1987.
19. Cabrera C, Artacho R and Giménez R: Beneficial effects of green tea - a review. J Am Coll Nutr 25: 79-99, 2006.
20. Yamamoto T, Staples J, Wataha J, et al: Protective effects of EGCG on salivary gland cells treated with gamma-radiation or cis-platinum(II)diammine dichloride. Anticancer Res 24, 3065-3073, 2004.
21. Zheng J, Lee HC, Bin Sattar MM, Huang Y and Bian JS: Cardioprotective effects of epigallocatechin-3-gallate against doxorubicin-induced cardiomyocyte injury. Eur J Pharmacol 652: 82-88, 2011.
22. Ohe Y, Ohashi Y, Kubota K, et al: Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan. Ann Oncol 18: 317-323, 2007.
23. Liang G, Tang A, Lin X, et al: Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer. Int J Oncol 37: 111-123, 2010.
24. Kurahashi N1, Sasazuki S, Iwasaki M, Inoue M, Tsugane S; JPHC Study Group: Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am J Epidemiol 167: 71-77, 2008.
25. Paschka AG, Butler R and Young CY: Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate. Cancer Lett 130: 1-7, 1998.
26. Fujiki H: Two stages of cancer prevention with green tea. J Cancer Res Clin Oncol 125: 589-597, 1999.
27. Inoue M, Tajima K, Mizutani M, Iwata H, Iwase T, Miura S, Hirose K, Hamajima N and Tominaga S: Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett 167: 175-182, 2001.
28. Orner GA, Dashwood WM, Blum CA, Díaz GD, Li Q and Dashwood RH: Suppression of tumorigenesis in the Apc(min) mouse: down-regulation of beta-catenin signaling by a combination of tea plus sulindac. Carcinogenesis 24: 263-267, 2003.
29. Gao YT, McLaughlin JK, Blot WJ, Ji BT, Dai Q and Fraumeni JF Jr.: Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst 86: 855-858, 1994.
30. Hibasami H, Komiya T, Achiwa Y, Ohnishi K, Kojima T, Nakanishi K, Akashi K and Hara Y: Induction of apoptosis in human stomach cancer cells by green tea catechins. Oncol Rep 5: 527-529, 1998.
31. Takada M, Nakamura Y, Koizumi T, Toyama H, Kamigaki T, Suzuki Y, Takeyama Y and Kuroda Y: Suppression of human pancreatic carcinoma cell growth and invasion by epigallocatechin-3-gallate. Pancreas 25: 45-48, 2002.
32. Fujimoto N, Sueoka N, Sueoka E, Okabe S, Suganuma M, Harada M and Fujiki H: Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1. Int J Oncol 20: 1233-1239, 2002.